Rémi Droller
Life Science Partners
Medicine
Am-pharma BV
Netherlands
Biography
Rémi joined Kurma Life Science Partners in September 2010. Prior to that, he held positions at CDC Innovation from 2000 to 2003 and at AGF Private Equity (now Idinvest Partners) from 2003 to 2010, where he was in charge of developing the life sciences investment activity. During this period, Rémi served on the board of several investee companies such as Adocia, Bioalliance Pharma (listed on Euronext), Domain Therapeutics, Integragen (listed on Alternext), Novagali Pharma (listed on Euronext), Prosensa and Zealand Pharma (listed on Nasdaq OMX Copenhagen).
Research Interest
Finance and Innovation management
